RCUS
#1533
Arcus Biosciences, Inc. Common Stock
30.6 0 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.55%
Monthly Change
+11.31%
6 month change
+50.22%
Year Change
+186.79%
Previous Close
30.7 7
Open
30.5 5
Low
30.5 1
High
30.8 0
Volume
425
Financials
- Market Capitalization 3.9 B
- Employee 601
- Founded 2015
- CEO -
- Website www.arcusbio.com
- Headquarter Delaware, United States
- FIGI BBG00DQD26W3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.24
Price to sales ratio
10.36
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1522 |  VKTX Viking Therapeutics, Inc. - Common Stock | 33.86 USD | -1.51% | -2.67% | +0.03% | +22.42% | 3.95 B USD | ||
| 1523 |  DNLI Denali Therapeutics Inc. - Common Stock | 24.67 USD | +0.41% | -2.26% | +3.31% | +52.57% | 3.94 B USD | ||
| 1545 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.38 USD | +2.25% | +0.35% | +10.70% | +80.35% | 3.86 B USD | ||
| 1557 |  ABCL AbCellera Biologics Inc. - Common Shares | 12.40 USD | +1.31% | +7.08% | +130.48% | +188.37% | 3.80 B USD |
Frequently asked questions about Arcus Biosciences, Inc.
What is the Arcus Biosciences, Inc. stock price today?
The current price of Arcus Biosciences, Inc. (RCUS) is 30.6. Over the past 24 hours, the stock has changed by -0.55%. Follow the RCUS chart for real-time price dynamics.
What is the stock ticker of Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. trades under the ticker RCUS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Arcus Biosciences, Inc. stock going up?
RCUS has changed by +2.14% over the last week, +11.31% over the last month, and +186.79% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. currently has a market capitalization of 3.9 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Arcus Biosciences, Inc. earnings last quarter?
Last quarter, Arcus Biosciences, Inc. reported earnings of -0.72 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Arcus Biosciences, Inc. revenue for the last quarter?
Arcus Biosciences, Inc. reported quarterly revenue of 41 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Arcus Biosciences, Inc. net income for the last quarter?
Arcus Biosciences, Inc. reported net income of -91 M for the last quarter. The previous quarter showed -128 M, which means net income changed by +28.91%.
How many employees does Arcus Biosciences, Inc. have?
As of the latest available data, Arcus Biosciences, Inc. has 601 employees. Workforce size can provide additional context about the company's scale and operations.
What is Arcus Biosciences, Inc. EBITDA?
Arcus Biosciences, Inc. EBITDA is -98 M, and its EBITDA margin is -239.02%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Arcus Biosciences, Inc. stock?
You can buy Arcus Biosciences, Inc. (RCUS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Arcus Biosciences, Inc. stock?
Investing in Arcus Biosciences, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RCUS chart and related analysis on metatrader.com as part of your research.